EGFR and neoplasm: Graviola decreased estrogen receptor (EGFR) expression, tumor marker (CA15-3) antigenicity, ROS production and lipid peroxidation, but promoted apoptosis in 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in vivo (208).